The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

MLA

Roberta Maltoni, et al. “The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects.” Frontiers in Cell and Developmental Biology, vol. 9, Nov. 2021. EBSCOhost, https://doi.org/10.3389/fcell.2021.772216/full.

APA

Roberta Maltoni, Maurizio Puccetti, Manolo D’Arcangelo, Angelo Delmonte, Elisabetta Petracci, Sara Bravaccini, Giuseppe Bronte, Federico Cappuzzo, Lucio Crinò, Sara Ravaioli, & Maria Maddalena Tumedei. (2021). The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.772216/full

Chicago

Roberta Maltoni, Maurizio Puccetti, Manolo D’Arcangelo, Angelo Delmonte, Elisabetta Petracci, Sara Bravaccini, Giuseppe Bronte, et al. 2021. “The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects.” Frontiers in Cell and Developmental Biology 9 (November). doi:10.3389/fcell.2021.772216/full.